Skip to main content
Equibles

FLSC · Frazier Life Sciences Acquisition Corp. II

Track FLSC — free

Use FLSC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research FLSC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$10.29 -0.06 (-0.58%) At close · Oct 19
Rebalance outlook locked
Market Cap
$99.56M
Shares
9.68M
Volume · Oct 19 142.08K Avg daily vol (4 sessions) 373.98K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$10.29 Open$10.40 Day$10.29–10.63 Available close range$10.29–10.49 Avg vol available · 4d374K Short vol37% DataOct 2026–Oct 2026

The closing range uses available history since Oct 14, 2026; less than a full year is stored.

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Sell Momentum Limited Sentiment Bullish Fundamentals Limited Quant / Vol Low
Market backdrop VIX 18.4 · elevated Equity put/call 0.55
Technical
price trend
Sell
50 / 200-day cross No cross
52-week position 0%
near low
Momentum
relative strength
Limited
Not enough data for a confident read.
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Accumulating
Net +$3.0M over 90 days · 0% sells
Short interest Flat
No short-interest data
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Low
Volatility 27%
annualized · 1-yr
Max drawdown −2%
past year

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
1 · 1 · 0
50 / 200-day cross
No cross Neutral
52-week position
0% Bearish
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Accumulating
Net +$3.0M over 90 days · 0% sells
Short interest Flat
No short-interest data
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its available closing range
Range low $10 Now $10 · 0% Range high $10

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Shell Companies — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
FLSC
Frazier Life Sciences Acquisition Corp. II
this stock
$99.56M — — — —
VYLR
Vylor Inc.
 $48.31B — — — —
CLUS
Cluster Group Holdings Ltd Co
 $8.00B — — — —
DMII
Drugs Made In America Acquisition II Corp.
 $648.15M +2.8% — — 0.2%
EVAC
EQV Ventures Acquisition Corp. II
 $603.18M +2.9% — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Volume
Short vol %
37%
As of
Oct 19, 2026
Short Total
View
Smart Money
Insider Trades Net buying
Net (90d)
+$3.0M
Buyers / Sellers
1 / 0
Buyers Sellers
View
Filings
SEC Filings
Latest
8-K
Filed
Oct 15, 2026
This year
2

Frazier Life Sciences Acquisition Corp. II completed its IPO on October 15, 2026, selling 7,500,000 Class A ordinary shares at $10.00 per share for $75,000,000 in gross proceeds, plus 300,000 private placement shares at $10.00 per share for $3,000,000.

View

Performance

5D 20D 120D MTD YTD
FLSC — — — — —
SPY -1.5% -0.9% +7.7% +0.5% +12.4%
vs SPY — — — — —
Key facts CIK 2153598